Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute.
Carter
Barry L
BL
Division of Clinical and Administrative Pharmacy, Rm 527, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA. barry.carter@uiowa.edu
Einhorn
Paula T
PT
Brands
Michael
M
He
Jiang
J
Cutler
Jeffrey A
JA
Whelton
Paul K
PK
Bakris
George L
GL
Brancati
Frederick L
FL
Cushman
William C
WC
Oparil
Suzanne
S
Wright
Jackson T
JT
D001786:Blood Glucose; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced* / Q000209:etiology / Q000378:metabolism; D006973:Hypertension / Q000188:drug therapy*; D007008:Hypokalemia / Q000139:chemically induced* / Q000150:complications / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D054555:National Heart, Lung, and Blood Institute (U.S.); D011188:Potassium / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D012106:Research; D049971:Thiazides / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States
D001786:Blood Glucose; D004232:Diuretics; D007328:Insulin; D049971:Thiazides; D011188:Potassium